CJC-1295 (No DAC) Research Guide
Educational Overview • Scientific Background • Current Research
Article Details
🕒 Estimated Reading Time: 8–10 minutes
📅 Last Reviewed: August 2026
📚 Research Category: Growth Hormone & Endocrine Research
🔬 Evidence Level: Human & Preclinical Research
📖 Article Type: Educational Research Guide
What Is CJC-1295 (No DAC)?
CJC-1295 (No DAC) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) developed for laboratory research involving the regulation of natural growth hormone secretion.
Unlike the longer-acting DAC version, CJC-1295 without Drug Affinity Complex (DAC) has a significantly shorter biological half-life. This shorter duration allows researchers to investigate growth hormone release in a manner that more closely resembles the body's natural pulsatile secretion pattern.
Rather than supplying growth hormone directly, CJC-1295 (No DAC) stimulates GHRH receptors located in the anterior pituitary, encouraging the release of endogenous growth hormone. Because of this mechanism, it has become an important research tool in studies involving endocrine physiology, growth hormone regulation, metabolism, body composition, aging biology, and pituitary signaling.
Check it out here: https://researchpeps.org/product/cjc-1295-no-dac-5mg/
Research Snapshot
Category Information
Research Name CJC-1295 (No DAC)
Classification Growth Hormone-Releasing Hormone (GHRH) Analog
Research Status Investigational Research Peptide
Primary Research Areas Growth Hormone Physiology, Endocrinology, IGF-1 Biology, Metabolism, Aging Research
Evidence Level Human & Preclinical Research
Related Hormone Growth Hormone-Releasing Hormone (GHRH)
At a Glance
What is CJC-1295 (No DAC)?
A synthetic Growth Hormone-Releasing Hormone analog designed to stimulate the body's natural production of growth hormone.
Why is it researched?
Scientists investigate CJC-1295 (No DAC) to better understand endocrine regulation, pituitary signaling, metabolism, body composition, and healthy aging.
Current Evidence
Human and laboratory research continues examining growth hormone physiology and IGF-1 regulation using CJC-1295 (No DAC).
Human Use
This article summarizes published scientific literature for educational purposes only.
Why Researchers Study CJC-1295 (No DAC)
Researchers continue investigating CJC-1295 (No DAC) because it stimulates the body's own growth hormone release while maintaining natural endocrine feedback mechanisms.
Its shorter duration of action also allows researchers to study pulsatile hormone release more closely than longer-acting GHRH analogs.
Current research interests include:
🧬 Growth Hormone Physiology
📈 IGF-1 Regulation
⚖️ Metabolic Biology
💪 Body Composition
🧠 Pituitary Function
😴 Sleep Biology
🔬 Healthy Aging Research
Current Areas of Scientific Investigation
🧬 Growth Hormone Physiology
Researchers study how CJC-1295 (No DAC) activates pituitary GHRH receptors to stimulate endogenous growth hormone secretion.
📈 IGF-1 Biology
Because growth hormone stimulates production of insulin-like growth factor-1 (IGF-1), researchers investigate how GHRH signaling influences downstream endocrine pathways.
⚖️ Metabolism Research
Growth hormone signaling affects numerous metabolic pathways, making CJC-1295 (No DAC) valuable in metabolism-related laboratory studies.
💪 Body Composition Research
Research continues exploring relationships between endogenous growth hormone signaling, lean tissue biology, adipose tissue, and overall body composition.
😴 Sleep & Circadian Biology
Natural growth hormone secretion occurs primarily during deep sleep, making CJC-1295 (No DAC) useful for studying sleep-associated endocrine physiology.
🧠 Healthy Aging Research
Age-related reductions in endogenous growth hormone production continue to make GHRH analogs an important area of endocrine aging research.
CJC-1295 (No DAC) vs CJC-1295 DAC
One important distinction is the presence or absence of the Drug Affinity Complex (DAC).
CJC-1295 (No DAC)
✔ Shorter half-life
✔ Mimics natural hormone pulses
✔ Frequently studied alongside pulsatile endocrine physiology
CJC-1295 DAC
✔ Longer half-life
✔ Extended stimulation of GHRH receptors
✔ Different pharmacokinetic profile
Both compounds continue to be investigated in endocrine research, but they are not interchangeable.
Quick Facts
✔ Synthetic GHRH analog
✔ No Drug Affinity Complex (DAC)
✔ Investigated in human and laboratory research
✔ Stimulates endogenous growth hormone secretion
✔ Studied in metabolism and endocrine physiology
Important Scientific Considerations
CJC-1295 (No DAC) stimulates natural growth hormone production rather than supplying growth hormone directly.
Its shorter duration of activity allows researchers to investigate endocrine signaling under conditions that more closely resemble physiologic hormone pulses.
Although substantial research exists, additional investigation continues regarding long-term endocrine physiology and broader biological applications.
Key Takeaways
✔ CJC-1295 (No DAC) is a synthetic Growth Hormone-Releasing Hormone analog.
✔ It stimulates the body's natural release of growth hormone.
✔ Researchers investigate pituitary signaling, metabolism, and endocrine physiology.
✔ Human and laboratory studies continue examining its biological activity.
✔ Additional research remains ongoing.
Continue Exploring Related Research
Related Growth Hormone & Endocrine Research
Another Growth Hormone-Releasing Hormone analog investigated in endocrine physiology.
Explore research involving metabolism, endocrine regulation, and body composition.
➡️ CJC-1295 + Ipamorelin Research Guide
Combination peptide research involving GHRH and ghrelin receptor signaling.
Selective growth hormone secretagogue research.
Research involving reproductive hormone regulation and hypothalamic signaling.
Investigational research involving gonadotropin biology and endocrine physiology.
Further Reading
The publications below represent foundational peer-reviewed literature related to Growth Hormone-Releasing Hormone physiology and CJC-1295 research.
Selected References
CJC-1295
1. Teichman SL, et al. (2006). Prolonged stimulation of growth hormone and IGF-1 secretion by CJC-1295 in healthy adults. Journal of Clinical Endocrinology & Metabolism.
2. Veldhuis JD, et al. (2004). Mechanisms regulating pulsatile growth hormone secretion. Endocrine Reviews.
Growth Hormone Physiology
3. Mayo KE, et al. (2000). Growth Hormone-Releasing Hormone: Physiology and clinical applications. Endocrine Reviews.
4. Giustina A, Veldhuis JD. (1998). Pathophysiology of the somatotropic axis. Endocrine Reviews.
Endocrine Regulation
5. Ho KY, et al. (1987). Effects of age on growth hormone secretion in healthy adults. Journal of Clinical Investigation.
6. Veldhuis JD, Iranmanesh A. (2006). Neuroendocrine regulation of growth hormone secretion. Endocrine Reviews.
Educational Notice
The information presented in this article is intended solely for educational and informational purposes regarding published scientific research.
CJC-1295 (No DAC) is an investigational research peptide. References to scientific studies describe published laboratory, preclinical, and human research and should not be interpreted as evidence of safety or effectiveness for any particular use.
This content is not medical advice and should not be used to make healthcare decisions.